An amphotropic retroviral vector expressing a mutant gsp oncogene: Effects on human thyroid cells in vitro

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 8, 1997, Pages 2702-2709

  Ivan, M ^a   Ludgate, M ^a   Gire, V ^a   Bond, J A ^a   Wynford Thomas, D ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CYCLIC AMP; HEMAGGLUTININ;

ALPHA CHAIN; AMINO ACID SEQUENCE; ARTICLE; CELL SIZE; CYTOSKELETON; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; TARGET CELL; THYROID CARCINOMA;

ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETINAE; CULTURE MEDIA; FETAL BLOOD; GAP JUNCTIONS; GENE EXPRESSION; GENETIC VECTORS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HEMAGGLUTININS; HUMANS; POINT MUTATION; POLYMERASE CHAIN REACTION; RETROVIRIDAE; RNA-DIRECTED DNA POLYMERASE; THYROID GLAND; THYROTROPIN; TRANSFECTION;

EID: 0030754654     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.8.2702     Document Type: Article

References (47)

1. s and stimulate the adenylyl cyclase in human pituitary tumours. Nature. 340:692-696.
2. O'Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NL. 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinogen. 4:345-349.
3. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C, Monier R. 1991 gsp mutations in human thyroid tumours. Oncogene. 6:677-679.
4. Russo D, Arturi F, Wicker R, et al. 1995 Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 80:1347-1351.
5. Parma J, Duprez L, Van Sande, et al. 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:649-651.
6. Russo D, Arturi F, Suarez HG, et al. 1996 Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 81:1548-1551.
7. Roger PP, Dumont JE. 1987 Thyrotropin is a potent growth factor for normal human thyroid cells in primary culture. Biochem Biophys Res Commun. 149:707-711.
8. Williams DW, Wynford-Thomas D, Williams ED. 1987 Control of human thyroid follicular cell proliferation in suspension and monolayer culture. Mol Cell Endocrinol. 51:33-40.
9. Roger PP, Taton M, Van Sande J, Dumont JE. 1988 Mitogenic effects of thyrotropin and adenosine 3′,5′-monophosphate in differentiated normal human thyroid cells in vitro. J Clin Endocrinol Metab. 66:1158-1165.
10. 2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J. 11:537-542.
11. Michiels FM, Caillou B, Talbot M, et al. 1994 Oncogenic potential of guanine nucleotide stimulatory factor a subunit in thyroid glands of transgenic mice. Proc Natl Acad Sci USA. 91:10488-10492.
12. Weinstein L, Shenker A, Gejman PV, Friedman E, Spiegel AM. 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 325:1688-1695.
13. Feuillan PP, Shawker T, Rose SR, Jones J, Jeevanram RK, Nisula B. 1990 Thyroid abnormalities in the McCune-Albright syndrome: ultrasonography and hormonal studies. J Clin Endocrinol Metab. 71:1596-1601.
14. Duprez L, Parma J, Van Sande J, et al. 1994 Germline mutations in the thyrotropin receptor gene cause non autoimmune autosomal dominant hyperthyroidism. Nat Genet. 7:396-401.
15. Kopp P, Van Sande J, Parma J, et al. 1995 Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med. 332:150-154.
16. Derwahl M. 1996 Editorial: TSH receptor and Gs-α gene mutations in the pathogenesis of toxic thyroid adenomas: a note of caution. J Clin Endocrinol Metab. 81:2783-2785.
17. sα. Biochem Biophys Res Commun. 168:1184-1193.
18. s stimulates growth and differentiation of FRTL5 cells. Oncogene. 9:3647-3653.
19. sα. Mol Endocrinol. 9:1279-1287.
20. Wynford-Thomas D. 1993 In vitro models of thyroid cancer. Cancer Surv. 16:115-134.
21. Bond J, Dawson T, Lemoine N, Wynford-Thomas D. 1992 Effect of serum growth factors and phorbol ester on growth and survival of human thyroid epithelial cells expressing mutant ras. Mol Carcinogen. 5:129-135.
22. Bond J, Wyllie FS, Rowson J, Radulescu A, Wynford-Thomas D. 1994 In vitro reconstruction of tumour initiation in a human epithelium. Oncogene. 9:281-290.
23. Williams DW, Williams ED, Wynord-Thomas D. 1988 Loss of dependence in IGF-1 for proliferation of human thyroid adenoma cells. Br J Cancer. 57:535-539.
24. sα gene. Proc Natl Acad Sci USA. 85:2081-2085.
25. Danos O, Mulligan RC. 1988 Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA. 85:6460-6464.
26. Wyllie FS, Lemoine NR, Barton CM, Dawson TP, Bond JA, Wynford-Thomas D. 1993 Direct growth stimulation of normal epithelial cells by mutant p53. Mol Carcinogen. 7:83-88.
27. Munari-Silem Y, Audebet C, Rousset B. 1991 Hormonal control of cell-to-cell communication: regulation by thyrotropin of the gap junction-mediated dye transfer between thyroid cells. Endocrinology. 128:3299-3309.
28. Lemoine NR, Staddon S, Bond J, Wyllie FS, Shaw JJ, Wynford-Thomas D. 1990 Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene. Oncogene. 5:1833-1837.
29. Bond JA, Wyllie FS, Ivan M, Dawson T, Wynford-Thomas D. 1993 A variant epithelial sub-population in normal thyroid with high proliferative capacity in vitro. Mol Cell Endocrinol. 93:175-183.
30. Bond JA, Ness GO, Rowson J, Ivan M, White D, Wynford-Thomas D. 1996 Spontaneous de-differentiation correlates with extended lifespan in transformed thyroid epithelial cells: an epigenetic mechanism of tumour progression? Int J Cancer. 67:563-572.
31. Roger PP, Baptist M, Dumont JE. 1992 A mechanism generating heterogeneity in thyroid epithelial cells: suppression of the thyrotropin/cAMP-depndent mitogenic pathway after cell division induced by cAMP-independent factors. J Cell Biol. 117:383-393.
32. Kraiem Z, Sadeh O, Sobel E. 1990 Thyrotropin, acting at least partially via adenosine 3′,5′-monophosphate, exerts both mitogenic and antimitogenic effects in cultured human thyroid cells. J Clin Endocrinol Metab. 70:497-502.
33. Miller DG, Adam MA, Miller D. 1990 Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol. 10:4239-4242.
34. Laurence TS, Beers WH, Gilula NB. 1978 Transmission of hormonal stimulation by cell-to-cell communication. Nature. 272:501-506.
35. Murray SA, Fletcher WH. 1984 Hormone-induced intercellular signal transfer dissociates cyclic AMP-dependent protein kinase. J Cell Biol. 98:1710-1719.
36. Davidson JS, Baumgarten IM, Harley EH. 1986 Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Biochem Biophys Res Commun. 134:29-36.
37. Davidson JS, Baumgarten IM. 1988 Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationship. J Pharmacol Exp Ther. 246:1104-1107.
38. Maenhaut C, Lefort A, Libert F, et al. 1990 Function, proliferation and differentiation of the dog and human thyrocyte. Horm Metab Res. 23:51-61.
39. sα (Q227L) show enhanced hormone secretion and proliferation. Mol Cell Endocrinol. 127:41-47.
40. Watkins FA, Moss J, Vaughan M. 1980 Effects of GTP on choleragen-catalyzed ADP ribosylation of membrane and soluble proteins. J Biol Chem. 255:3959-3963.
41. Iiri T, Ohoka Y, Ui M, Katada T. 1992 Modification of the function of pertussis toxin substrate GTP-binding protein by cholera toxin-catalyzed ADP-ribosylation. J Biol Chem. 267:1020-1026.
42. Glineur C, Locht C. 1994 Importance of ADP-ribosylation in the morphological changes of PC12 cells induced by cholera toxin. Infect Immun. 62:4176-4185.
43. Sheffler LA, Wink DA, Melillo G, Cox GW. 1995 Characterisation of oxide-stimulated ADP-ribosylation of various proteins from the mouse macrophage cell line ANA-1 using sodium nitroprusside and the novel nitric oxide-donating compound diethylamine dinitric oxide. J Leukocyte Biol. 57:152-159.
44. Studer H, Peter HJ, Gerber H. 1989 Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth. Endocr Rev. 10:125-135.
45. Studer H, Derwahl M. 1995 Mechanism of nonneoplastic endocrine hyperplasia- a changing concept: a review focused on the thyroid gland. Endocr Rev. 16:411-426.
46. Bidey SP, Tomlinson S. 1988 The regulation and integration of thyroid follicular differentiation and function. Clin Endocrinol (Oxf). 28:423-444.
47. Wynford-Thomas D, Stringer BMJ, Williams ED. 1982 Dissociation of growth and function in the rat thyroid during prolonged goitrogen administration. Acta Endocrinol (Copenh). 101:210-216.